Search Results - "HALLADIN, NATALIE"

Oxidative and inflammatory biomarkers of ischemia and reperfusion injuries by Halladin, Natalie Løvland

“…Ischemia-reperfusion injuries occur when the blood supply to an organ or tissue is temporarily cut-off and then restored. Even though the restoration of blood…”
Get full text

Melatonin for pre- and postoperative anxiety in adults by Hansen, Melissa V, Halladin, Natalie L, Rosenberg, Jacob, Gögenur, Ismail, Møller, Ann Merete

“…Anxiety in relation to surgery is a well-known problem. Melatonin offers an atoxic alternative to benzodiazepines in ameliorating this condition in the pre-…”
Get more information

Effects of intracoronary melatonin on ischemia–reperfusion injury in ST-elevation myocardial infarction by Ekeløf, Sarah V., Halladin, Natalie L., Jensen, Svend E., Zaremba, Tomas, Aarøe, Jens, Kjærgaard, Benedict, Simonsen, Carsten W., Rosenberg, Jacob, Gögenur, Ismail

“…Acute coronary occlusion is effectively treated by primary percutaneous coronary intervention. However, myocardial ischemia–reperfusion injury is at the moment…”
Get full text

An adverse drug event manager facilitates spontaneous reporting of adverse drug reactions by Vinther, Siri, Klarskov, Pia, Borgeskov, Hanne, Darsø, Perle, Christophersen, Anette Kvindebjerg, Borck, Bille, Christensen, Catrine, Hansen, Melissa Voigt, Halladin, Natalie Monica Løvland, Christensen, Mikkel Bring, Harboe, Kirstine Moll, Lund, Marie, Jimenez-Solem, Espen

“…Spontaneous reporting of adverse drug reactions (ADRs) is used for continuous risk-benefit evaluation of marketed pharmaceutical products and for signal…”
Get full text

Intracoronary and systemic melatonin to patients with acute myocardial infarction: protocol for the IMPACT trial by Halladin, Natalie L, Busch, Sarah Ekeløf, Jensen, Svend Eggert, Hansen, Henrik Steen, Zaremba, Tomas, Aarøe, Jens, Rosenberg, Jacob, Gögenur, Ismail

“…Ischaemia-reperfusion injury following acute myocardial infarctions (AMI) is an unavoidable consequence of the primary percutaneous coronary intervention…”
Get full text

Melatonin does not affect oxidative/inflammatory biomarkers in a closed-chest porcine model of acute myocardial infarction by Halladin, Natalie L, Ekeløf, Sarah, Jensen, Svend Eggert, Aarøe, Jens, Kjærgaard, Benedict, Heegaard, Peter M H, Lykkesfeldt, Jens, Rosenberg, Jacob, Gögenur, Ismail

“…To test whether melatonin reduces oxidative and inflammatory biomarkers in a closed-chest porcine model of acute myocardial infarction. Twenty pigs were…”
Get full text

Efficacy and Safety of IDegLira Versus Basal-Bolus Insulin Therapy in Patients With Type 2 Diabetes Uncontrolled on Metformin and Basal Insulin: The DUAL VII Randomized Clinical Trial by Billings, Liana K, Doshi, Ankur, Gouet, Didier, Oviedo, Alejandra, Rodbard, Helena W, Tentolouris, Nikolaos, Grøn, Randi, Halladin, Natalie, Jodar, Esteban

“…In patients with uncontrolled type 2 diabetes on basal insulin, prandial insulin may be initiated. We assessed the efficacy and safety of initiating insulin…”
Get full text

Safety and efficacy of IDegLira titrated once weekly versus twice weekly in patients with type 2 diabetes uncontrolled on oral antidiabetic drugs: DUAL VI randomized clinical trial by Harris, Stewart B., Kocsis, Győző, Prager, Rudolf, Ridge, Terry, Chandarana, Keval, Halladin, Natalie, Jabbour, Serge

“…Aims To compare the safety and efficacy of a simpler titration algorithm for insulin degludec/liraglutide (IDegLira) with that used in previous DUAL trials in…”
Get full text

Superior efficacy of insulin degludec/liraglutide versus insulin glargine U100 as add‐on to sodium‐glucose co‐transporter‐2 inhibitor therapy: A randomized clinical trial in people with uncontrolled type 2 diabetes by Philis‐Tsimikas, Athena, Billings, Liana K., Busch, Robert, Portillo, Cristobal Morales, Sahay, Rakesh, Halladin, Natalie, Eggert, Sarah, Begtrup, Kamilla, Harris, Stewart

“…Aim To investigate the efficacy and safety of insulin degludec/liraglutide (IDegLira) versus insulin glargine 100 units/mL (IGlar U100) as add‐on to…”
Get full text

Durability of insulin degludec plus liraglutide versus insulin glargine U100 as initial injectable therapy in type 2 diabetes (DUAL VIII): a multicentre, open-label, phase 3b, randomised controlled trial by Aroda, Vanita R, González-Galvez, Guillermo, Grøn, Randi, Halladin, Natalie, Haluzík, Martin, Jermendy, György, Kok, Adri, Őrsy, Petra, Sabbah, Mohamed, Sesti, Giorgio, Silver, Robert

“…Durability of glycaemic control might reduce disease burden and improve long-term outcomes. DUAL VIII investigated the durability of insulin degludec plus…”
Get full text

Efficacy of IDegLira vs. Basal-Bolus Therapy in Subjects with Type 2 Diabetes in DUAL VII by Baseline Characteristics by BILLINGS, LIANA K., KLONOFF, DAVID C., TENTOLOURIS, NIKOLAOS, GRØN, RANDI, HALLADIN, NATALIE, JÓDAR, ESTEBAN

“…In 5subjects with type 2 diabetes uncontrolled on metformin and basal insulin, the DUAL VII trial (NCT02420262) demonstrated that a once-daily injection of…”
Get full text

EFFICACY AND SAFETY OF IDEGLIRA IN OLDER PATIENTS WITH TYPE 2 DIABETES by Lingvay, Ildiko, Handelsman, Yehuda, Linjawi, Sultan, Vilsbøll, Tina, Halladin, Natalie, Ranc, Kristina, Liebl, Andreas

“…The efficacy and safety of insulin degludec/liraglutide (IDegLira) in older patients has not yet been reported. This analysis aimed to evaluate the efficacy…”
Get more information

A greater proportion of participants with type 2 diabetes achieve treatment targets with insulin degludec/liraglutide versus insulin glargine 100 units/mL at 26 weeks: DUAL VIII, a randomized trial designed to resemble clinical practice by Sesti, Giorgio, Bardtrum, Lars, Dagdelen, Selcuk, Halladin, Natalie, Haluzík, Martin, Őrsy, Petra, Rodríguez, Martin, Aroda, Vanita R.

“…This report presents the efficacy and safety of insulin degludec/liraglutide (IDegLira) versus insulin glargine 100 units/mL (IGlar U100) as initial injectable…”
Get full text

A greater proportion of participants with type 2 diabetes achieve treatment targets with insulin degludec/liraglutide versus insulin glargine 100units/mL at 26weeks: DUAL VIII, a randomized trial designed to resemble clinical practice by Sesti, Giorgio, Bardtrum, Lars, Dagdelen, Selcuk, Halladin, Natalie, Haluzík, Martin, Őrsy, Petra, Rodríguez, Martin, Aroda, Vanita R

“…This report presents the efficacy and safety of insulin degludec/liraglutide (IDegLira) versus insulin glargine 100 units/mL (IGlar U100) as initial injectable…”
Get full text

Superior Efficacy of Insulin Degludec/Liraglutide (IDegLira) vs. Insulin Glargine (IGlar U100) as Add-On to Sodium-Glucose Cotransporter-2 Inhibitor (SGLT2i) ± Oral Antidiabetic Drug (OAD) Therapy in Patients with Type 2 Diabetes (T2D)—DUAL IX Trial by PHILIS-TSIMIKAS, ATHENA, BILLINGS, LIANA, BUSCH, ROBERT S., PORTILLO, CRISTOBAL MORALES, SAHAY, RAKESH, HALLADIN, NATALIE, JUHL, RUTA GRONSKYTE, HARRIS, STEWART

“…This study investigated the safety and efficacy of IDegLira as add-on to SGLT2i. In this 26-week, phase 3b, open-label trial, 420 patients with T2D…”
Get full text

147-OR: DUAL VIII: Significantly Longer Time to Treatment Intensification with Insulin Degludec/Liraglutide (IDegLira) vs. Insulin Glargine (IGlar U100) in a 104-Week (Wk) Randomized Trial Mirroring Clinical Practice by ARODA, VANITA R., GONZALEZ-GALVEZ, GUILLERMO, HALUZIK, MARTIN, SILVER, ROBERT J., GRØN, RANDI, HALLADIN, NATALIE, ÖRSY, PETRA, SESTI, GIORGIO

“…Patients (pts) (n=1012) with T2D (A1C 7-11%) on oral antidiabetic drugs (OADs) were randomized 1:1 to open label IDegLira or IGlar U100 in a 104 week trial to…”
Get full text

Patient-Reported Outcomes (PROs) for Insulin Degludec/Liraglutide (IDegLira) vs. Insulin Glargine (IGlar U100) as Add-On to Sodium-Glucose Co-Transporter-2 Inhibitor (SGLT2i) ± Oral Antidiabetic Drug (OAD) Therapy in Patients with Type 2 Diabetes (T2D)—DUAL IX Trial by BROD, MERYL, BILLINGS, LIANA K., BUSCH, ROBERT S., HARRIS, STEWART, PORTILLO, CRISTOBAL MORALES, SAHAY, RAKESH, BUSK, ANNE, EGGERT, SARAH, HALLADIN, NATALIE, PHILIS-TSIMIKAS, ATHENA

“…In DUAL IX, a 26-week, phase 3b, treat-to-target, open-label trial, patients with uncontrolled T2D on SGLT2i ± OADs (N=420) were randomized 1:1 to once-daily…”
Get full text

The Benefit of Insulin Degludec/Liraglutide (IDegLira) Compared With Basal-Bolus Insulin Therapy is Consistent Across Participant Subgroups With Type 2 Diabetes in the DUAL VII Randomized Trial by Billings, Liana K., Agner, Bue F. Ross, Altuntas, Yuksel, Grøn, Randi, Halladin, Natalie, Klonoff, David C., Tentolouris, Nikolaos, Jódar, Esteban

“…Background: Insulin degludec/liraglutide (IDegLira) results in glycated hemoglobin (HbA1c) levels comparable with basal-bolus (BB) therapy. Here, we assessed…”
Get full text

Effect of Intracoronary and Intravenous Melatonin on Myocardial Salvage Index in Patients with ST-Elevation Myocardial Infarction: a Randomized Placebo Controlled Trial by Ekeloef, Sarah, Halladin, Natalie, Fonnes, Siv, Jensen, Svend Eggert, Zaremba, Tomas, Rosenberg, Jacob, Jonsson, Grete, Aarøe, Jens, Gasbjerg, Lærke Smidt, Rosenkilde, Mette Marie, Gögenur, Ismail

“…Melatonin has attenuated myocardial ischemia reperfusion injury in experimental studies. We hypothesized that the administration of melatonin during acute…”
Get full text

138 - Efficacy of IDegLira vs. Basal–Bolus Therapy in Subjects with Type 2 Diabetes in DUAL VII by Baseline Characteristics by Billings, Liana K., Altuntas, Yuksel, Klonoff, David C., Tentolouris, Nikolaos, Grøn, Randi, Halladin, Natalie, Chan-Remillard, Sylvia, Jódar, Esteban

Get full text